Healthcare Technology Report August 18, 2025
Dexcom has announced a major leadership transition as part of its long-term growth strategy, naming current President and Chief Operating Officer Jake Leach as the company’s next Chief Executive Officer effective January 1, 2026. Leach, a 21-year veteran of the company, has overseen Dexcom’s biosensing platforms since its first commercial system and has held senior leadership roles in technology, operations, and corporate strategy. His appointment follows a period of strong financial performance and...







